However, our study also suggests the relative plateau phase is relative indeed, as the TTV-levels show a decreasing trend after this first year which continues until a final stable phase develops after 24 months, and that high TTV levels are especially predictive of long-term adverse outcome if samples are taken after 24 months.
← all excerpts
Torquetenovirus Serum Load and Long-Term Outcomes in Renal Transplant Recipients.
1
—
—